Earth Science Tech Inc. (OTCQB: ETST), a healthcare, pharmacy, and telemedicine holding company, has achieved a significant milestone by uplisting to the OTCQB Venture Market. This move, effective September 17, 2026, underscores the company's commitment to enhancing its visibility and credibility within the investment community. The uplisting follows a strong first quarter in which revenue increased 3% to $9.0 million and net income surged 57% to $715,697, signaling improved operational efficiency and profitability.
In addition to the uplisting, Earth Science Tech has completed two strategic acquisitions: Meduvo LLC, a compounding pharmacy, and Zoolzy LLC, a pharmaceutical distributor. These acquisitions are expected to expand the company's opportunities in human therapeutics and animal health, further diversifying its business portfolio and creating synergies across its healthcare platform. The integration of Meduvo and Zoolzy aligns with Earth Science Tech's strategy to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment.
At the annual shareholder meeting on August 31, investors approved several measures that support the company's future growth. These include authorizing potential future uplisting to the Nasdaq or NYSE, retiring the dual-class voting structure to simplify governance, and adopting a new non-dilutive executive compensation framework. These developments reflect Earth Science Tech's focus on enhancing corporate governance, aligning management interests with shareholder value, and positioning the company for continued expansion.
The uplisting to OTCQB is particularly important as it may increase liquidity and attract a broader investor base. It also sets the stage for a potential move to a national exchange, which could further enhance the company's profile and access to capital. For more details on Earth Science Tech's progress, visit https://ibn.fm/hrUOF. The company's newsroom at https://ibn.fm/ETST provides ongoing updates.
Earth Science Tech's core value proposition lies in the seamless integration of patient care, from consultation to fulfillment, achieved through the synergy of specialized subsidiaries. To learn more, please visit www.EarthScienceTech.com.
The announcement was disseminated through BioMedWire, a specialized communications platform focused on the biotechnology, biomedical sciences, and life sciences sectors. BioMedWire is part of the Dynamic Brand Portfolio at IBN, which offers extensive wire solutions through InvestorWire and editorial syndication to 5,000+ outlets. BioMedWire also provides press release enhancement and social media distribution, among other corporate communications solutions.
Investors should note the terms of use and disclaimers applicable to all content provided by BioMedWire, available at https://www.BioMedWire.com/Disclaimer. For more information, visit www.BioMedWire.com.
